These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 11044089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
    Boretti FS, Leutenegger CM, Mislin C, Hofmann-Lehmann R, König S, Schroff M, Junghans C, Fehr D, Huettner SW, Habel A, Flynn JN, Aubert A, Pedersen NC, Wittig B, Lutz H.
    AIDS; 2000 Aug 18; 14(12):1749-57. PubMed ID: 10985311
    [Abstract] [Full Text] [Related]

  • 3. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
    Dunham SP, Flynn JN, Rigby MA, Macdonald J, Bruce J, Cannon C, Golder MC, Hanlon L, Harbour DA, Mackay NA, Spibey N, Jarrett O, Neil JC.
    Vaccine; 2002 Feb 22; 20(11-12):1483-96. PubMed ID: 11858854
    [Abstract] [Full Text] [Related]

  • 4. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S, Leutenegger CM, Dean GA, Steckbeck JD, Cole KS, Sparger EE.
    J Virol; 2007 Jan 22; 81(2):465-73. PubMed ID: 17079309
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM, Hofmann-Lehmann R, Holznagel E, Cuisinier AM, Wolfensberger C, Duquesne V, Cronier J, Allenspach K, Aubert A, Ossent P, Lutz H.
    AIDS Res Hum Retroviruses; 1998 Feb 10; 14(3):275-83. PubMed ID: 9491919
    [Abstract] [Full Text] [Related]

  • 10. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts.
    Giannecchini S, Isola P, Sichi O, Matteucci D, Pistello M, Zaccaro L, Del Mauro D, Bendinelli M.
    J Virol; 2002 Jul 10; 76(14):6882-92. PubMed ID: 12072489
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
    Cuisinier AM, Mallet V, Meyer A, Caldora C, Aubert A.
    Vaccine; 1997 Jul 10; 15(10):1085-94. PubMed ID: 9269051
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN, Beatty JA, Cannon CA, Stephens EB, Hosie MJ, Neil JC, Jarrett O.
    AIDS Res Hum Retroviruses; 1995 Sep 10; 11(9):1107-13. PubMed ID: 8554908
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats.
    Burkhard MJ, Valenski L, Leavell S, Dean GA, Tompkins WA.
    Vaccine; 2002 Dec 13; 21(3-4):258-68. PubMed ID: 12450701
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.